Skip to Content

Visitor RestrictionsDon't Delay Care: We are taking all necessary precautions to keep you safe while we care for you. Virtual Care | In-Person Care

Visitor Restrictions: Visitors are not allowed in our hospitals, cancer centers and outpatient locations with limited exceptions. Get the Details.

Symptom assessment, donation information and other updates available on our COVID-19 page.

Publications, Platform & Poster Presentations

Journal Article Publications

  • Evaluation of the Accuracy of Different Methods Used to Estimate Ideal Body Weight in the Pediatric Population J Pediatr Pharmacol Ther 2019;24(5):421-430 - Kenny Kang, Randy Absher, Elizabeth Farrington, Renee Ackley and Tsz- Yin So
  • A Review on the Use of Cystic Fibrosis Transmembrane Conductance Regulator Gene Modulators in Pediatric Patients. J Pediatr Health Care 2019; 33:356-364 - Michael Bitonti, Laura Fritts and Tsz-Yin So
  • The Use of Codeine and Tramadol in the Pediatric Population – What is the Verdict Now? J Pediatr Health Care 2019;33:117-123 - Megan Fortenberry, Justin Crowder and Tsz-Yin So
  • A Literature Review on the Use of Dornase Alfa in Pediatric Patients with Lower Respiratory Tract Illnesses other than Cystic Fibrosis. Arch Pediatr Neonatol 2018;1(1):26-35 - Radha Patel and Tsz-Yin So
  • Evaluation of the Efficacy of a Onetime Injectable Dexamethasone Administered Orally in the Pediatric Emergency Department for Asthma Exacerbation. J Pediatr Pharmacol Ther 2017;22(5):326-331 - McCallister A, So TY. 
  • Treatment of Pediatric Clostridium difficile Infection: A Review on Treatment Efficacy and Economic Value. Infect Drug Resist 2017;10:365-375 - D’Ostroph AR, So TY. 
  • Assessing Medication Adherence at a Student-Run Free Health Clinic.  Journal of Student Run Free Clinics. Vol 3 No 1. Sept 17, 2017. - Lam FW, Kaplan MC, Gazda NP, Shah MD, Toler JA, Scolaro, KL. 
  • Impact of Developing Adult Ketamine Order Panels for the Emergency Department. Hosp Pharm 2017;1-5 - Baird H, Rumbarger R. 
  • Real-world Experience with Oritavancin Therapy in Invasive Gram-Positive Infections. Infect Dis Ther 2017;6:277-289 - Stewart C, Turner M, Frens J, Snider C, Smith J.  
  • Elements of Success for Transitioning to the Role of Director of Pharmacy. Am J Health Syst Pharm 2017;74:557-561 - Granko RP, Thompson JM, Morton CS, Little JD. 
  • Comparison of Two Medication Therapy Management Practice Models on Return on Investment. J Pharm Pract 2017;30(3):282-285 - Gazda NP, Ferreri S. Berenbrok L. 
  • Strategy for Pharmacy Data Management. Am J Health Syst Pharm 2017;74:79-85 - Wolfe A, Hess L, La MK, Pappas AL, Moore R, Granko RP, Daniels, R. 
  • Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population. Clin Drug Investig 2017; 37(7):625-634 - Corey A, So TY. 
  • Primary Immunization of Human Papillomavirus Vaccine in the Pediatric Population – What Is the Verdict Now? Clin Pediatr (Phila) 2017;56(7):605-615 - Jones AN, Barlett JW, Bates RA, So TY. 
  • The Use of Citrulline for Pediatric Pulmonary Hypertension. Res J Clin Pediatr 2017;1:1-6 - Yang S, So TY. 
  • Pharmacy Practice: Exploring the Relationship between SSRIs and Sodium Levels in an Older Adult Population. Inov Pharm. 2016;7(4): Article 14. - Anderson SL, Johnston N. 
  • Pharmacists’ Impact on Opportunistic Infection Prophylaxis in Patients with HIV/AIDS. J Hosp Infect 2016;94(4):389-392 - Schatz K, Guffey W, Maccia M, Templin M, Rector K. 
  • Medication Use Evaluation of Dronedarone in Comparison to Amiodarone. Inov Pharm. 2016;7(4): Article 18. - Corey A, Johnston N. 
  • Medication Reconciliation Limitations: Observation of the Medication Reconciliation Process in the Emergency Department by Two Immersion Pharmacy Students. Inov Pharm. 2016;7(4): Article 4. - Chong C, Haile A. 
  • Medication Adherence Survey: A First Year Pharmacy Immersion Students’ Perspective. Inov Pharm. 2016;7(3): Article 8. - Ortiz Lopez CF, Li M, Johnston N. 
  • Patient Medication Use: Interpreting the Results of a Patient Medication Safety Survey by Phase I Immersion Pharmacy Students. Inov Pharm. 2016;7(3): Article 4. - Li M, Ortiz Lopez CF, Johnston N, et al. 
  • Attention Deficit Hyperactive Disorder and Occurrence of Tic Disorders in Children and Adolescents-What is the Verdict Now? Curr Pediatr Rev. 2016;12(3):230-238 - Cooke T, So TY. 
  • Standardize Practice to Identify IV Errors. Pharmacy Purchasing and Products, May 2016, page 20 - Granko RP, McCallister A. 
  • Transitioning antimicrobials from intravenous to oral in pediatric acute uncomplicated osteomyelitis. World J Clin Pediatr 2016; 5(3): 244-250 - Batchelder N, So TY. 
  • Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report. J Pediatric Pharmacol Ther. 2016;21(1):85-91 - Badik J, Chen J, Letvak K, So TY.  
  • Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population. Cardio Ther 2016;5(1):19-41 - von Vajna E, Alam, R, So TY. 
  • The Use of Penicillin for the Prevention of Pneumococcal Infection in Pediatric Patients with Sickle Cell Disease. J Pediatr Sci 2015;7:e246 - Lawuyi B, Basham J, So TY. 
  • The Risk of Musculoskeletal Adverse Events with Fluuroquinolones in Children: What is the Verdict Now? Clin Pediatr 2016; 55(2):107-110 - Binz J, Adler C, So TY. 
  • Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease. J Pediatric Pharmacol Ther. 2015;20(3):163-177 - Saneeymehri S, Baker K, So TY. 
  • Promoting Pharmacy Business Success through the Implementation of a Departmental Operating Review Series. Am J Health Syst Pharm 2015; 72:610-613 - Granko RP, Lamm M. 

  • Assessing the Personal Performance And Professional Self-development Potential of a Pharmacy Management Practitioner. Am J Health Syst Pharm 2015; 72:149-157 - Granko RP, Wolfe A, Morton C,

Website & Magazine Articles